Navigation Links
Susan G. Komen for the Cure(R)'s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors
Date:5/29/2008

campaign. It will be unveiled at a private luncheon hosted by The Links, Incorporated, in Washington, D.C. on June 6. The luncheon will include many Circle of Promise ambassadors, corporate partners and advocates.

Circle of Promise ambassadors help spread the message that more African-American women are likely to die from breast cancer than any other race despite being the least likely to be diagnosed with the disease. These ambassadors work nationally and within their communities to urge others within the African-American community to reclaim their health and register at circleofpromise.org. Everyone can help to rewrite the story on African Americans and breast cancer by making a promise to practice breast self awareness, getting involved through Circle of Promise, and telling friends to join Circle of Promise.

Komen for the Cure celebrates the 25th anniversary of its Susan G. Komen Race for the Cure(R) Series, the largest series of 5K runs/fitness in the world, in Washington, D.C. on June 7. Local ambassadors, advocates and breast cancer survivors will come together to help raise funds for research, education, screening and treatment.

Launched in October 2007, the Circle of Promise (http://www.circleofpromise.org) campaign was created by Susan G. Komen for the Cure to educate, empower and mobilize the African-American community in the fight against breast cancer. Through this effort, Komen hopes to rewrite the story on African Americans and breast cancer by decreasing the African American mortality rate, which is 18 percent higher than for Caucasian women. Susan G. Komen for the Cure's Circle of Promise has joined forces with ESSENCE Magazine, Ford Motor Company and The Links, Incorporated to recruit 100,000 African-American women to join Circle of Promise and serve as local ambassadors within their communities.

About Susan G. Komen for the Cure(R)

Nancy G. Brinker promi
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Susan G. Komen for the Cure(R) Celebrity Ambassadors to Convene in Nations Capital to Help Race for the Cure, End Breast Cancer Forever
2. Susan G. Komen for the Cure(R) Encourages Nation to Go Passionately Pink by Donning Pink, Donating Funds to End Breast Cancer Forever
3. Saia Partners with Susan G. Komen for the Cure
4. Susan G. Komen for the Cures(R) Moddelmog Calls for Congress to Launch Colossal Cancer Crusade
5. Great Mothers Day Gift - Supporting Susan G. Komen for the Cure
6. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
7. Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position
8. Susan Powter The Politics of Stupid: The Cure for Obesity
9. Cynthia Nixon to Serve as Ambassador for Susan G. Komen for the Cure(R)
10. Susan G. Komen for the Cure(R) Calls on Policymakers to Address Unfairness in Breast Cancer Incidence and Mortality
11. Massachusetts Affiliate of Susan G. Komen for the Cure(R) to Challenge States Leaders to Strengthen Breast Cancer Services
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:New approach to sickle-cell disease shows promise in mice 2
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 1OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 2OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 3Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 1Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 2Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 1Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 2